Is this email not displaying correctly? View it in your browser.
Newswise - News for Journalists
Newswise Special Wire
Tuesday, October 22, 2019

Public edition |

Newswise Cancer Research Wire for 22-Oct-2019

Cancer Research Wire

Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.

Cancer Research

Exposure to Environmental PCBs Impairs Brain Function In Mice

Human-made toxic chemicals that linger indefinitely in the environment disrupt the performance of critical helper cells in the mouse brain, leading to impaired function over long-term exposures.

– Georgetown University Medical Center

Embargo expired on 22-Oct-2019 at 08:00 ET

Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA

Women with an aggressive, less-common type of breast cancer, known as triple-negative, versus a more common form of the disease, could be differentiated from each other by a panel of 17 small RNA molecules that are directly influenced by genetic alte...

– Georgetown Lombardi Comprehensive Cancer Center

Oncotarget; CERSI; U01FD004319; P30-CA051008

Embargo expired on 22-Oct-2019 at 00:05 ET

Using Plasma Jets to Deliver Cancer Medication

Modern advances in oncology have significantly improved cancer survival rates. However, personalized treatment methods are necessary, since tumors may behave differently for different patients. At the AVS 66th International Symposium and Exhibition, ...

– AVS: Science and Technology of Materials, Interfaces, and Processing

AVS 66th International Symposium and Exhibition

Embargo expired on 21-Oct-2019 at 16:40 ET

Machine Learning’s Next Frontier: Epigenetic Drug Discovery

Scientists at Sanford Burnham Prebys Medical Discovery Institute have developed a machine-learning algorithm that gleans information from microscope images—allowing for high-throughput epigenetic drug screens that could unlock new treatments for ca...

– Sanford Burnham Prebys Medical Discovery Institute

eLife; R01NS066278; FDN143312

Novel Study Documents Marked Slowdown of Cell Division Rates in Old Age

In a novel study comparing healthy cells from people in their 20s with cells from people in their 80s, researchers at the Johns Hopkins Kimmel Cancer Center say they have documented that cell division rates appear to consistently and markedly slow do...

– Johns Hopkins Medicine

Proceedings of the National Academy of Sciences; P30-CA006973, R37-CA43460, R01-CA57345, R01-CA179991, R00-CA190889, P50-CA62924

Systematic Collection of Patient-Reported Outcome Measures in Breast Cancer Care Has a Promising Impact on Patients, Providers, and Care Processes

Value in Health, the official journal of ISPOR, announced the publication of new research showing that systematic collection of patient-reported outcome measures in breast cancer care has a promising impact on patients, providers, and care processes/...

– ISPOR—The Professional Society for Health Economics and Outcomes Research

Value in Health, Oct-2019

Blood test identifies risk of relapse for B cell lymphoma

New research shows how a simple blood test can better identify which patients with diffuse large B cell lymphoma are at risk for relapse.

– University of Chicago Medical Center

Blood Advances

Creatine powers T cells’ fight against cancer

The study, conducted in mice, is the first to show that creatine uptake is critical to the anti-tumor activities of killer T cells, the foot soldiers of the immune system.

– UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Journal of Experimental Medicine

Scientists build genomic research platform to help treat cervical cancer

Yale Cancer Center scientists have built a powerful genomic research platform to study cervical cancer, a disease that often is untreatable if it progresses after surgery or primary chemo-radiation treatment.

– Yale Cancer Center


Changes in Chromosome Caps May be A Marker for Tumor Aggression in Neurofibromatosis Type 1

Researchers at the Johns Hopkins Kimmel Cancer Center report that their study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggr...

– Johns Hopkins Medicine

Acta Neuropathologica Communications ; W81XWH-18-1-0496, 2T32CA009110-39A1, P30 CA006973

A simpler way to make some medicines

Organic chemists have figured out how to synthesize the most common molecule arrangement in medicine, a scientific discovery that could change the way a number of drugs – including one most commonly used to treat ovarian cancer – are produced. Th...

– Ohio State University


Exercise can now be prescribed like medicine for people with and beyond cancer

It’s well known that exercise is good for preventing and treating many forms of heart disease, but less commonly known are the benefits of physical activity for people living with and beyond cancer. A new initiative called Moving Through Cancer --...

– Penn State College of Medicine

A Cancer Journal for Clinicians

Preclinical research helps explain why fatty livers are more susceptible to cancer

Fatty liver disease is contributing to an increase in liver cancer and basic scientists at The University of Texas Health Science at Houston (UTHealth) have new insight as to why.

– University of Texas Health Science Center at Houston

Cancer Research

Antibody eradicates leukemia stem cells

Now, in experiments in mice as well as isolated human cancer cells, UCLA researchers have discovered a way to eliminate the CML stem cells. Their approach uses an antibody to block a protein that the stem cells rely on to grow. The advance, described...

– UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Journal of Clinical Investigation

Cancer Experts and Features

Expert Panel: Cancer Treatment Plans Should IncludeTailored Exercise Prescriptions

New guidance from exercise oncology experts recommend systematic use of an “exercise prescription” by health care workers and fitness professionals in designing and delivering exercise programs that aim to lower the risk of developing certain can...

– American College of Sports Medicine (ACSM)

Medicine & Science in Sports & Exercise®; CA: A Cancer Journal for Clinicians

New Precision Immunotherapy Clinic Matches Patients to Latest Cancer Therapies

New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.

– University of California San Diego Health

2-D or 3-D?

Breast medical oncologist Ursa Brown-Glaberman, MD, wants to catch life-threatening breast cancers earlier, when these women have many more treatment choices and a much better chance of beating the disease. She leads the TMIST study at the UNM Cance...

– University of New Mexico Comprehensive Cancer Center

UCLA opens pioneering CAR T clinical trial aimed at extending the lives of people diagnosed with the most common types of lymphoma and leukemia

This month, the UCLA Jonsson Cancer Center has launched a pioneering chimeric antigen receptor (CAR) T cell immunotherapy trial that will attack cancer cells by simultaneously recognizing two targets – CD19 and CD20 – that are expressed on B-cell...

– University of California, Los Angeles (UCLA), Health Sciences

University of Chicago to help lead national effort to make cancer research data more useful, accessible and impactful

The University of Chicago will help lead an $8.8 million effort to make the vast quantity of cancer research data being produced more accessible and useful to clinicians and researchers around the world.

– University of Chicago

Oncology Pharmacists: An Essential Partner in the Cancer Journey

One of the hallmarks of a National Cancer Institute-designated Comprehensive Cancer Center is the unique oncology expertise exhibited by its clinical team, including board certified oncology pharmacists. A Rutgers Cancer Institute of New Jersey expe...

Expert Available

– Rutgers Cancer Institute of New Jersey

Breast cancer surgeon to discuss surgical treatment of breast cancer

– Mercy Medical Center

Developments In Breast Cancer Diagnosis By Radiation Oncologist Expert

– Mercy Medical Center

Cancer Announcements

St. Jude Children’s Research Hospital and IAEA partner to tackle childhood cancers in developing countries

The International Atomic Energy Agency (IAEA) and St. Jude Children’s Research Hospital are joining forces to combat childhood cancers in developing countries.

– St. Jude Children's Research Hospital

Embargo expired on 18-Oct-2019 at 07:00 ET

MD Anderson and Varian partner to optimize radiation oncology treatment

The University of Texas MD Anderson Cancer Center and Varian today announced a new strategic collaboration to develop an integrated software platform to streamline review of radiation oncology treatment plans.

– University of Texas M. D. Anderson Cancer Center

Embargo expired on 17-Oct-2019 at 11:00 ET

The Association of American Cancer Institutes Launches Public Policy Resource Library

The AACI Public Policy Resource Library aims to enable cancer centers and partners in the cancer advocacy community to share resources to foster collaboration, promote cancer prevention, and spur the development of sound public health policy at the s...

– Association of American Cancer Institutes (AACI)

SHRO Founder Presented with Career Award and Appointed Chair of Italian Cancer Association FONICAP

Sbarro Health Research Organization founder and Director, Antonio Giordano, M.D., Ph.D., has been recognized with a career award "for the great contributions he has made and which he will continue to make to science, medicine and research.

– Sbarro Health Research Organization (SHRO)

UC San Diego Moores Cancer Center’s J. Silvio Gutkind Joins National Academy of Medicine

J. Silvio Gutkind elected to National Academy of Medicine for his contributions to the understanding of cancer signaling networks and pioneering the study of the PIK3CA-mTOR signaling circuitry in head and neck cancer.

– University of California San Diego Health

Effort to Examine Alzheimer’s Impact on Pain Processing

A new multisite study funded by the National Institute on Aging will examine whether co-occurring Alzheimer’s disease and stage 4 breast or prostate cancer alters pain perception, potentially leading to undertreated cancer pain.

– Vanderbilt University Medical Center


Stephan Grupp, MD, PhD, Elected to the National Academy of Medicine

Stephan Grupp, MD, PhD, Chief of the Cell Therapy and Transplant Section in the Division of Oncology and Director of the Cancer Immunotherapy Program at Children’s Hospital of Philadelphia, has been elected into the National Academy of Medicine (NA...

– Children's Hospital of Philadelphia

Two University of Chicago Medicine physicians elected to National Academy of Medicine for 2019

Two University of Chicago faculty members, Vineet Arora, MD, MAPP, and Ernst Lengyel, MD, PhD, have been elected to membership in the National Academy of Medicine.

– University of Chicago Medical Center

$12.5 Million Grant Awarded to Wistar Extends Federal Support of the Institute’s Quest for Improved Targeted Therapies for Melanoma

Wistar and collaborating institutions have received a major grant from the National Institutes of Health to further research on new melanoma targeted therapies integrating the role of the tumor microenvironment in influencing response to therapy and...

– Wistar Institute

Dr. Talia Golan Named Recipient of the Mort and Brigitte Harris Pancreas Cancer Award

The Henry Ford Pancreatic Cancer Center (HFPCC) and Henry Ford Innovation Institute have named Talia Golan, M.D., head of the Sheba Pancreatic Cancer Center, the largest pancreatic cancer care center in Israel, the recipient of the inaugural Mort and...

– Henry Ford Health System

UTEP Receives $19M to Study Cancer Affecting Mexican-Americans

This grant will provide significant research funds for UTEP cancer scientists to understand better the molecular mechanisms, and possible environmental and lifestyle factors that contribute to this multifaceted disease.

– University of Texas at El Paso

Ocean Medical Center Welcomes Prashant Desai, M.D., as Medical Director of Radiation Oncology

Hackensack Meridian Health Ocean Medical Center is pleased to welcome Prashant Desai, M.D. to its medical staff. Dr. Desai is a specially trained radiation oncologist and has been appointed medical director of radiation oncology at Ocean Medical Cent...

– Hackensack Meridian Health





 Edit My Preferences
 Contact Us
 Newswise Home
 Newswise Contact Directory
 Expert Queries
 Presspass Application

More News from:

 UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

 Penn State College of Medicine

 University of California, Los Angeles (UCLA), Health Sciences

 University of Texas M. D. Anderson Cancer Center

 AVS: Science and Technology of Materials, Interfaces, and Processing

 University of California San Diego Health

 Washington University in St. Louis

Subscribe / Unsubscribe
Edit my preferences

© 2019 Newswise, Inc. All Rights Reserved.

265 Turkey Sag Trail Suite 102, #110 Palmyra VA 22963 | 434-296-9417

 Contact Us